Stephen Oh: Building the Future of Hematology Through Research Training
Stephen Oh, Professor at Washington University School of Medicine in St. Louis, shared a post on LinkedIn:
“Delighted to share the news that our NHLBI-supported Molecular Hematology T32 training grant has been officially renewed through Year 55!
One of the longest running active T32 programs, this award is a testament to the exceptional environment for hematology research that has been a defining hallmark of WashU for many decades.
The success of this T32 is very much a reflection of the outstanding trainees who received support from this program and have gone on to impactful careers in biomedical research.
I am especially pleased to partner with Grant Challen who has joined the leadership team of our T32 as Co-Program Director. We look forward to the opportunity to support the next generation of hematology researchers! ”

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines